dlaminithabiso2@gmail.com +27 (0) 79 375 3278
Background:
Mlungisi Thabiso Dlamini joined KRISP in January 2017 as a PhD Research Fellow under the mentorship of Prof. Tulio de Oliveira, as part of the CAPRISA Professional Development Programme (PDP). He holds a Masters degree in Medical Science (Medical Microbiology) where he was investigating the role of Mycobacterium tuberculosis curli pili (MTP) in inducing host immune response in pulmonary epithelial cells using RNA-sequencing. His PhD work focuses on the application of next-generation sequencing to identify known and novel drug resistance-conferring mutations in the whole genome of drug-resistant M. tuberculosis strains with an aim of formulating improved strategies to reduce the development and spread of drug-resistant tuberculosis in KwaZulu-Natal.
Affiliations:
PhD Research Fellow: KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal.
NRF-DST PDP Research Fellow: Centre for the Aids Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal.
Education:
Master of Medical Science (Medical Microbiology), Department of Medical Microbiology, University of KwaZulu-Natal (2016).
Bachelor of Medical Science Honours (Medical Microbiology), Department of Medical Microbiology, University of KwaZulu-Natal (2013).
Bachelor of Science (Microbiology and Cell Biology), University of KwaZulu-Natal (2012).
Whole genome sequencing for drug-resistant tuberculosismanagement in South Africa: What gaps would this address andwhat are the challenges to implementation?.
Dlamini MT, Lessells R, Iketleng T, de Oliveira T, Journal of Clinical TB and Other Mycobacterial Dis (2019), https://doi.org/10.1016/j.jctube.2019.100115:.
Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges.
Iketleng T, Lessells R, Dlamini MT, Mogashoa T, Mupfumi L, Moyo S, Gaseitsiwe S, de Oliveira T, Tuberculosis Research and Treatment (2018), https://doi.org/10.1155/2018/1298542:.
Vaccine: SA expat Dr Soon-Shiong launches R3 billion initiative - The South African - 2021-09-27
Covid-19: Infections could rise by 10% per day after lockdown lifts - top scientists - News24 - 2020-05-01
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira